Recurrent intrathoracic thymomas: Potential prognostic importance of cell-cycle protein expression

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 1, 2009, Pages 40-45

  Mineo, Tommaso C ^a   Ambrogi, Vincenzo ^a   Baldi, Alfonso ^b   Pompeo, Eugenio ^a   Mineo, Davide ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CISPLATIN; ETOPOSIDE; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE FREE INTERVAL; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG EMBOLISM; MALE; MEDIASTINUM TUMOR; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADICAL THYMOMECTOMY; RECURRENT DISEASE; RECURRENT INTRATHORACIC THYMOMA; REMISSION; RESPIRATORY FAILURE; RISK FACTOR; SURVIVAL RATE; THYMECTOMY; THYMOMA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RHO GTP-BINDING PROTEINS; SURVIVAL RATE; THYMOMA; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67649401765     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.11.048     Document Type: Article

References (26)

1. Maggi G., Casadio C., Cavallo A., Cianci R., Molinatti M., and Ruffini E. Thymoma-results of 241 operated cases. Ann Thorac Surg 51 (1991) 152-156
2. Regnard J.-F., Magdeleinat P., and Dromer C. Prognostic factors and long-term results after thymoma resection-a series of 307 patients. J Thorac Cardiovasc Surg 112 (1996) 376-384
3. Wilkins K.B., Sheikh E., Green R., Patel M., George S., Takano M., et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 230 (1999) 562-572
4. Strobel P., Bauer A., Puppe B., Kraushaar T., Krein A., Toyka K., et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 22 (2004) 1501-1509
5. Masaoka A., Monden Y., Nakahara K., and Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
6. Monden Y., Nakahara K., Iioka S., Nanjo S., Ohno K., Fujii Y., et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 39 (1985) 165-169
7. Kirschner P.A. Reoperation for thymoma: report of 23 cases. Ann Thorac Surg 49 (1990) 550-555
8. Mineo T.C., and Biancari F. Reoperation for recurrent thymoma: experience in seven patients and review of the literature. Ann Chir Gynaecol 85 (1996) 286-291
9. Regnard J.F., Zinzindohoue F., Magdeleinat P., Guibert L., Spaggiari L., and Levasseur P. Results of resection of the recurrence for recurrent thymomas. Ann Thorac Surg 64 (1997) 1593-1598
10. Ruffini E., Mancuso M., Oliaro A., Casadio C., Cavallo A., Cianci R., et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 113 (1997) 55-63
11. Haniuda M., Kondo R., Numanami H., Makiuchi A., Machida E., and Amano J. Recurrence of thymoma: clinicopathological features, re-operation, and outcome. J Surg Oncol 78 (2001) 183-189
12. Venuta F., Rendina E.A., Longo F., De Giacomo T., Anile M., Mercadante E., et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76 (2003) 866-872
13. Ciccone A.M., and Rendina E.A. Treatment of recurrent thymic tumors. Thorac Cardiovasc Surg 17 (2005) 27-31
14. Shimosato Y. Controversies surrounding the subclassification of thymoma. Cancer 74 (1994) 542-544
15. Lardinois D., and Rechsteiner R. Prognostic relevance of Masaoka and M. Hermelink classification in patients with thymic tumors. Ann Thorac Surg 69 (2000) 1550-1555
16. Wright C.D., Wain J.C., Wong D.R., Donahue D.M., Gaissert H.A., Grillo H.C., et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 130 (2005) 1413-1421
17. Rosai J. Histological typing of tumors of the thymus. World Health Organization International Histological Classification of Tumors. 2nd ed. (1999), Springer-Verlag, New York, Berlin
18. Chen G., Marx A., Wen-Hu C., Yong J., Puppe B., Strobel P., et al. New WHO classification predicts prognosis of thymic epithelial tumors. A clinicopathologic study of 200 thymoma cases from China. Cancer 95 (2002) 420-429
19. Kondo K., Yoshizawa K., Tsuyuguchi M., Kimura S., Sumitomo M., Morita J., et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77 (2004) 1183-1188
20. Sherr C.S. Cancer cell cycles. Science 274 (1996) 1672-1677
21. MacLachlan T.K., Sang N., and Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implication in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 5 (1995) 127-156
22. Mineo T.C., Ambrogi V., Mineo D., and Baldi A. Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression. Cancer 104 (2005) 2063-2071
23. Esposito V., Baldi A., Tonini G., Vincenzi B., Santini M., Ambrogi V., et al. Analysis of cell-cycle regulator proteins in non-small cell lung cancer. J Clin Pathol 57 (2004) 58-63
24. Nakagawa K., Asamura H., Matsuno Y., Suzuki K., Kondo H., Maeshima A., et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 126 (2003) 1134-1140
25. Inoue M., Starostik P., Zettl A., Strobel P., Schwarz S., Scaravilli F., et al. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res 63 (2003) 3708-3715
26. Pescarmona E., Rendina E.A., Venuta F., Ricci C., and Baroni C.D. Recurrent thymoma: evidence for histological progression. Histopathology 27 (1995) 445-449